PT861084E - Processo e composicao melhorados para cisplatina (cddp) terapeutica - Google Patents

Processo e composicao melhorados para cisplatina (cddp) terapeutica

Info

Publication number
PT861084E
PT861084E PT96939733T PT96939733T PT861084E PT 861084 E PT861084 E PT 861084E PT 96939733 T PT96939733 T PT 96939733T PT 96939733 T PT96939733 T PT 96939733T PT 861084 E PT861084 E PT 861084E
Authority
PT
Portugal
Prior art keywords
cisplatin
therapeutic
cddp
composition
improved process
Prior art date
Application number
PT96939733T
Other languages
English (en)
Inventor
Richard Maskiewicz
Kathleen V Roskos
Richard E Jones
Original Assignee
Matrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharma filed Critical Matrix Pharma
Publication of PT861084E publication Critical patent/PT861084E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT96939733T 1995-10-30 1996-10-29 Processo e composicao melhorados para cisplatina (cddp) terapeutica PT861084E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/550,086 US6077545A (en) 1995-10-30 1995-10-30 Process and composition for therapeutic cisplatin (CDDP)

Publications (1)

Publication Number Publication Date
PT861084E true PT861084E (pt) 2002-11-29

Family

ID=24195686

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96939733T PT861084E (pt) 1995-10-30 1996-10-29 Processo e composicao melhorados para cisplatina (cddp) terapeutica

Country Status (11)

Country Link
US (2) US6077545A (pt)
EP (1) EP0861084B1 (pt)
JP (1) JPH11514650A (pt)
KR (1) KR100486146B1 (pt)
AT (1) ATE219370T1 (pt)
AU (1) AU722687B2 (pt)
DE (1) DE69621942T2 (pt)
DK (1) DK0861084T3 (pt)
ES (1) ES2177817T3 (pt)
PT (1) PT861084E (pt)
WO (1) WO1997016196A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6722054B2 (en) 1998-11-12 2004-04-20 Atrix Laboratories, Inc. Process and delivery container for lyophilizing active agent
US6907679B2 (en) * 1998-11-12 2005-06-21 Qlt Usa, Inc. Method for lyophilizing an active agent
ES2193777T3 (es) 1998-12-23 2003-11-01 Orphan Medical Inc Disoluciones estables e inalterables microbiologicamente de sal de gamma-hidroxibutirato para el tratamiento de la narcolepsia.
IN186588B (pt) * 1999-07-28 2001-10-06 Vinod Daftary Gautam Dr
US20040214783A1 (en) 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US6566144B1 (en) * 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
KR20040048900A (ko) * 2001-09-24 2004-06-10 토스크, 인코포레이티드 감소된 독성 시스플라틴 포뮬레이션 및 이의 이용 방법
US9266785B2 (en) 2001-12-20 2016-02-23 Zero Gravity Solutions, Inc. Bioavailable minerals for plant health
US20120171130A1 (en) * 2001-12-20 2012-07-05 John Wayne Kennedy Mitigation of Animal and Plant Diseases Using Bioavailable Minerals
NZ538255A (en) * 2002-07-29 2006-11-30 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
EP2437781B1 (en) 2009-06-04 2013-07-24 Alk AG Stabilised composition comprising at least one adrenergic compound
UA122170C2 (uk) 2016-02-05 2020-09-25 Толмар Терапьютікс, Інк. Вентильована покривна пластина для масиву шприців
US20200206352A1 (en) * 2017-08-31 2020-07-02 Tohoku University Optimal osmotic range for a drug-containing solution suitable for lymphatic delivery
US20210205238A1 (en) 2017-10-10 2021-07-08 Merck Patent Gmbh Stabilized injectable pharmaceutical composition of l-epinephrine
KR20220146710A (ko) 2017-10-10 2022-11-01 메사추세츠 인스티튜트 오브 테크놀로지 치매를 예방, 경감 및/또는 치료하기 위한 시스템 및 방법
USD908916S1 (en) 2018-06-19 2021-01-26 Tolmar Therapeutics, Inc. Syringe restrictor plate
EP3586823A1 (en) 2018-06-25 2020-01-01 CAPNOMED GmbH Therapeutic composition, method and set for providing said therapeutic composition
US20220354794A1 (en) 2019-09-20 2022-11-10 Nivagen Pharmaceuticals, Inc. Lyophilized Compositions of Phenobarbital Sodium Salt
US11406598B2 (en) * 2019-09-20 2022-08-09 Nivagen Pharmaceuticals, Inc. Lyophilized compositions of phenobarbital sodium salt
WO2021216957A1 (en) * 2020-04-23 2021-10-28 Massachusetts Institute Of Technology Systems, devices, and methods for gamma entrainment using sensory stimuli to alleviate cognitive deficits and/or neuroinflammation induced by chemotherapy agents
CN113995714B (zh) * 2021-10-28 2023-04-28 杭州师范大学 一种顺铂交联的蛋白水凝胶及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
CA1275922C (en) * 1985-11-28 1990-11-06 Harunobu Amagase Treatment of cancer
US5100877A (en) * 1986-05-21 1992-03-31 Kuraray Co., Ltd. Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
US5214174A (en) * 1989-12-15 1993-05-25 Tsumura & Co. Platinum complex and anti-tumor agent comprising said complex as active ingredient
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug

Also Published As

Publication number Publication date
WO1997016196A1 (en) 1997-05-09
EP0861084A4 (en) 2000-02-02
DE69621942T2 (de) 2003-01-23
US6077545A (en) 2000-06-20
DK0861084T3 (da) 2002-10-07
US6224883B1 (en) 2001-05-01
KR100486146B1 (ko) 2005-08-05
JPH11514650A (ja) 1999-12-14
EP0861084A1 (en) 1998-09-02
KR20000064302A (ko) 2000-11-06
ATE219370T1 (de) 2002-07-15
ES2177817T3 (es) 2002-12-16
AU7682096A (en) 1997-05-22
DE69621942D1 (de) 2002-07-25
EP0861084B1 (en) 2002-06-19
AU722687B2 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
PT861084E (pt) Processo e composicao melhorados para cisplatina (cddp) terapeutica
MX9305444A (es) Derivados de rodanina como agentes hipoglucemicos y para el tratamiento de la enfermedad de alzheimer, composiciones farmaceuticas que los contienen y procedimiento para su preparacion.
CY1107351T1 (el) Καινοφανης μεταλλαγμενη μορφη απιμινασης αργινινης
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
LU92425I2 (fr) Dichlorure de radium Ra 2232 et ses dérivés pharmaceutiquement acceptables (XOFIGO®)
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
PT760649E (pt) Formulacoes a base de propionato de fluticasona
BR0007151A (pt) Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
SE9402880D0 (sv) New peptide derivatives
CA2063273A1 (en) Surfactant compositions and methods
TR200401775T4 (tr) 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
ES2170144T3 (es) Variantes que no se empalman de gp350/220.
NO960525L (no) Terapeutisk preparat
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
FI964448A (fi) Uusi biologisesti aktiivinen peptidi ja sen valmistus
HUT49886A (en) Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
CA2278223A1 (fr) Derives de la 1,4-dihydropyridine et leur utilisation en therapeutique
UA9703A (uk) Антипротеіназний засіб
AU1239788A (en) Benzylaminoaryl-dihydropyridinelactones, process for their preparation, and their use in medicaments